{"id":750272,"date":"2023-04-24T08:19:39","date_gmt":"2023-04-24T12:19:39","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-may-10-2023\/"},"modified":"2023-04-24T08:19:39","modified_gmt":"2023-04-24T12:19:39","slug":"catalyst-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-may-10-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-may-10-2023\/","title":{"rendered":"Catalyst Pharmaceuticals to Report First Quarter 2023 Financial Results on May 10, 2023"},"content":{"rendered":"

\nThe Company Will Host a Conference Call and Webcast on May 11, 2023, at 8:30 AM ET
\n<\/h2>\n
\n

CORAL GABLES, Fla., April 24, 2023 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc.\u00a0(\u201cCatalyst\u201d) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases, today announced that it will release its first-quarter 2023 financial results after market close on Wednesday,\u00a0May 10, 2023.<\/p>\n

Catalyst\u2019s management team will host a conference call and webcast the following morning, Thursday, May 11, 2023, at\u00a08:30 AM ET, to discuss the Company\u2019s financial results and provide a corporate update.<\/p>\n

\n Conference Call & Webcast Details<\/strong>\n <\/p>\n\n\n\n\n\n
Date\/Time:<\/td>\nMay 11, 2023, at\u00a08:30 AM ET<\/td>\n<\/tr>\n
US\/Canada Dial-in Number:<\/td>\n(877) 407-8912<\/td>\n<\/tr>\n
International Dial-in Number:<\/td>\n(201) 689-8059<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n<\/table>\n

A webcast and accompanying materials will be accessible under the Investors section on the Company\u2019s website at\u00a0www.catalystpharma.com<\/u><\/a>. A replay of the webcast will be available on the Catalyst website for 30 days following the date of the event.<\/p>\n

\n About\u00a0Catalyst Pharmaceuticals<\/strong>
\n
With exceptional patient focus, Catalyst is committed to developing and commercializing innovative first-in-class medicines that address rare neurological and epileptic diseases. Catalyst\u2019s\u00a0flagship U.S.\u00a0commercial product is FIRDAPSE\u00ae<\/sup>\u00a0(amifampridine) Tablets 10 mg, approved for the treatment of Lambert-Eaton myasthenic syndrome (\u201cLEMS\u201d) for adults and for children ages six to seventeen. In\u00a0January 2023, Catalyst acquired the\u00a0U.S.\u00a0commercial rights to FYCOMPA\u00ae<\/sup>\u00a0(perampanel) CIII, a prescription medicine approved in people with epilepsy aged four and older alone or with other medicines to treat partial-onset seizures with or without secondarily generalized seizures and with other medicines to treat primary generalized tonic-clonic seizures for people with epilepsy aged 12 and older. Further,\u00a0Canada\u2019s\u00a0national healthcare regulatory agency,\u00a0Health Canada, has approved the use of FIRDAPSE\u00a0for the treatment of adult patients in\u00a0Canada\u00a0with LEMS.<\/p>\n

For more information about\u00a0Catalyst Pharmaceuticals, Inc., visit the Company\u2019s website at: www.catalystpharma.com<\/u><\/a>. For the Full Prescribing and Safety Information for FIRDAPSE\u00ae<\/sup>, please visit\u00a0www.firdapse.com<\/u><\/a>. For the Full Prescribing Information for FYCOMPA\u00ae<\/sup>, please visit\u00a0www.fycompa.com<\/u><\/a>. See below for the Boxed Warning for FYCOMPA\u00ae<\/sup>:<\/p>\n

\n IMPORTANT SAFETY INFORMATION FOR FYCOMPA<\/strong>
\n
\n \u00ae<\/strong>
\n <\/sup>\n <\/p>\n\n\n\n
\n WARNING: SERIOUS PSYCHIATRIC AND BEHAVIORAL REACTIONS<\/strong><\/p>\n
    \n
  • Serious or life-threatening psychiatric and behavioral adverse reactions including aggression, hostility, irritability, anger, and homicidal ideation and threats have been reported in patients taking FYCOMPA<\/li>\n
  • These reactions occurred in patients with and without prior psychiatric history, prior aggressive behavior, or concomitant use of medications associated with hostility and aggression<\/li>\n
  • Advise patients and caregivers to contact a healthcare provider immediately if any of these reactions or changes in mood, behavior, or personality that are not typical for the patient are observed while taking FYCOMPA or after discontinuing FYCOMPA<\/li>\n
  • Closely monitor patients particularly during the titration period and at higher doses<\/li>\n
  • FYCOMPA should be reduced if these symptoms occur and should be discontinued immediately if symptoms are severe or are worsening<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
\u00a0<\/td>\n<\/tr>\n<\/table>\n

\n Forward-Looking Statements<\/strong>
\n
\n This press release contains forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties, which may cause Catalyst\u2019s actual results in future periods to differ materially from forecasted results. A number of factors, including those factors described in Catalyst\u2019s Annual Report on Form 10-K for the fiscal year 2022 and its other filings with the\u00a0U.S. Securities and Exchange Commission\u00a0(\u201cSEC\u201d), could adversely affect Catalyst. Copies of Catalyst\u2019s filings with the\u00a0SEC\u00a0are available from the\u00a0SEC, may be found on Catalyst\u2019s website, or may be obtained upon request from Catalyst. Catalyst does not undertake any obligation to update the information contained herein, which speaks only as of this date.<\/em>\n <\/p>\n

Source: Catalyst Pharmaceuticals, Inc.<\/p>\n<\/p>\n


\n
\n \n <\/div>\n

\n
Investor Contact\r\nMary Coleman\r\nCatalyst Pharmaceuticals, Inc.\r\n(305) 420-3200\r\nmcoleman@catalystpharma.com\r\n\r\nMedia Contact\r\nDavid Schull\r\nRusso Partners\r\n(858) 717-2310\r\ndavid.schull@russopartnersllc.com<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"
The Company Will Host a Conference Call and Webcast on May 11, 2023, at 8:30 AM ET CORAL GABLES, Fla., April 24, 2023 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc.\u00a0(\u201cCatalyst\u201d) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases, today announced that it will release its first-quarter 2023 financial results after market close on Wednesday,\u00a0May 10, 2023. Catalyst\u2019s management team will host a conference call and webcast the following morning, Thursday, May 11, 2023, at\u00a08:30 AM ET, to discuss the Company\u2019s financial results and provide a corporate update. Conference Call & Webcast Details Date\/Time: May 11, 2023, at\u00a08:30 AM ET US\/Canada Dial-in Number: (877) 407-8912 International Dial-in Number: (201) 689-8059 … <\/p>\n
Continue reading “Catalyst Pharmaceuticals to Report First Quarter 2023 Financial Results on May 10, 2023”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-750272","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nCatalyst Pharmaceuticals to Report First Quarter 2023 Financial Results on May 10, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-may-10-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Catalyst Pharmaceuticals to Report First Quarter 2023 Financial Results on May 10, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"The Company Will Host a Conference Call and Webcast on May 11, 2023, at 8:30 AM ET CORAL GABLES, Fla., April 24, 2023 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc.\u00a0(\u201cCatalyst\u201d) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases, today announced that it will release its first-quarter 2023 financial results after market close on Wednesday,\u00a0May 10, 2023. Catalyst\u2019s management team will host a conference call and webcast the following morning, Thursday, May 11, 2023, at\u00a08:30 AM ET, to discuss the Company\u2019s financial results and provide a corporate update. Conference Call & Webcast Details Date\/Time: May 11, 2023, at\u00a08:30 AM ET US\/Canada Dial-in Number: (877) 407-8912 International Dial-in Number: (201) 689-8059 … Continue reading "Catalyst Pharmaceuticals to Report First Quarter 2023 Financial Results on May 10, 2023"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-may-10-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-24T12:19:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMzEyNCM1NTQwNjU3IzIwMTk0OTE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/catalyst-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-may-10-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/catalyst-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-may-10-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Catalyst Pharmaceuticals to Report First Quarter 2023 Financial Results on May 10, 2023\",\"datePublished\":\"2023-04-24T12:19:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/catalyst-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-may-10-2023\\\/\"},\"wordCount\":600,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/catalyst-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-may-10-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgxMzEyNCM1NTQwNjU3IzIwMTk0OTE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/catalyst-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-may-10-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/catalyst-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-may-10-2023\\\/\",\"name\":\"Catalyst Pharmaceuticals to Report First Quarter 2023 Financial Results on May 10, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/catalyst-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-may-10-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/catalyst-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-may-10-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgxMzEyNCM1NTQwNjU3IzIwMTk0OTE=\",\"datePublished\":\"2023-04-24T12:19:39+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/catalyst-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-may-10-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/catalyst-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-may-10-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/catalyst-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-may-10-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgxMzEyNCM1NTQwNjU3IzIwMTk0OTE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgxMzEyNCM1NTQwNjU3IzIwMTk0OTE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/catalyst-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-may-10-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Catalyst Pharmaceuticals to Report First Quarter 2023 Financial Results on May 10, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Catalyst Pharmaceuticals to Report First Quarter 2023 Financial Results on May 10, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-may-10-2023\/","og_locale":"en_US","og_type":"article","og_title":"Catalyst Pharmaceuticals to Report First Quarter 2023 Financial Results on May 10, 2023 - Market Newsdesk","og_description":"The Company Will Host a Conference Call and Webcast on May 11, 2023, at 8:30 AM ET CORAL GABLES, Fla., April 24, 2023 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc.\u00a0(\u201cCatalyst\u201d) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases, today announced that it will release its first-quarter 2023 financial results after market close on Wednesday,\u00a0May 10, 2023. Catalyst\u2019s management team will host a conference call and webcast the following morning, Thursday, May 11, 2023, at\u00a08:30 AM ET, to discuss the Company\u2019s financial results and provide a corporate update. Conference Call & Webcast Details Date\/Time: May 11, 2023, at\u00a08:30 AM ET US\/Canada Dial-in Number: (877) 407-8912 International Dial-in Number: (201) 689-8059 … Continue reading \"Catalyst Pharmaceuticals to Report First Quarter 2023 Financial Results on May 10, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-may-10-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-04-24T12:19:39+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMzEyNCM1NTQwNjU3IzIwMTk0OTE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-may-10-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-may-10-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Catalyst Pharmaceuticals to Report First Quarter 2023 Financial Results on May 10, 2023","datePublished":"2023-04-24T12:19:39+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-may-10-2023\/"},"wordCount":600,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-may-10-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMzEyNCM1NTQwNjU3IzIwMTk0OTE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-may-10-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-may-10-2023\/","name":"Catalyst Pharmaceuticals to Report First Quarter 2023 Financial Results on May 10, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-may-10-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-may-10-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMzEyNCM1NTQwNjU3IzIwMTk0OTE=","datePublished":"2023-04-24T12:19:39+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-may-10-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-may-10-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-may-10-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMzEyNCM1NTQwNjU3IzIwMTk0OTE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMzEyNCM1NTQwNjU3IzIwMTk0OTE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/catalyst-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-may-10-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Catalyst Pharmaceuticals to Report First Quarter 2023 Financial Results on May 10, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/750272","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=750272"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/750272\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=750272"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=750272"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=750272"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}